Project Grant R01EB038757
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded UC Berkeley $2.33 million under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on September 15, 2025, with completion scheduled for August 31, 2029. This Project Grant supports the development of a CMOS-based miniaturized and disposable molecular detection system that enables sample-in-situ biosensing without requiring...
- Federal Grant Award Summary The University of California Santa Cruz received a $412,276 Project Grant from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded September 1, 2025, with completion targeted for August 31, 2027. This award supports the development and validation of an optofluidic biosensor integrating a waveguide spectrometer for spectral...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Leland Stanford Junior University a $127,926 Project Grant, effective August 1, 2025 through July 31, 2027, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). This award supports development of a subdermal, implantable monitoring platform designed to enable real-time, continuous detection and tracking of cardiac...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Regents of the University of California, San Francisco a Project Grant of $124,738 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) effective August 15, 2025, with completion targeted for July 31, 2027. This Pathway to Independence Award supports the development of dynamically reconfigurable materials for 4D...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering awarded $630,000 to the University of California, Los Angeles under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on September 1, 2025, with a completion date of August 31, 2028. This three-year project develops light-activated site-specific conjugation (LASIC) technology to advance the clinical translation of catheter-directed...
- Federal Project Grant Award Summary The University of California, Irvine received a $1,316,016 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 15, 2025, with completion targeted for August 31, 2029. The award funds research to develop label-free, single-molecule biosensing technology using metasurface-enhanced coherent anti-Stokes Raman scattering (SE-CARS). The project...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded $701,011 to The Regents of the University of California, San Francisco under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 1, 2025, for a project period extending through June 30, 2029. The research project, "Dissecting the Circuit-Level Mechanisms of Ultrasound Neuromodulation," will develop systematic...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded University of California, Berkeley a $641,360 Project Grant effective July 1, 2025, through May 31, 2029, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). This award funds development and validation of a novel distributed active programmable transmit (ADAPT) coil technology designed to advance radiofrequency (RF)...
- Federal Grant Award Summary Colorado State University received a $413,067 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective September 1, 2025, through August 31, 2027. The project aims to develop an improved class of electrochemical biosensors utilizing engineered binding proteins to simplify electrode fabrication and enhance...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Leland Stanford Junior University a $131,085 Project Grant on June 9, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop an ultrasound-interrogated implantable sensor for intracranial pressure (ICP) monitoring. The grant supports the design, fabrication, and preclinical validation of a passive,...
Federal Project Grant Award Summary The University of California, Santa Barbara received a $594,748 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop real-time, seconds-resolved measurement technology for amino acid homeostasis and its regulation. The research, funded from April 10, 2026 through January 31, 2030, focuses on adapting electrochemical aptamer-based (EAB) sensors—a platform technology developed by the research team—to enable unprecedented time-resolution in metabolic measurements. The primary deliverable involves translating this established sensor technology to monitor amino acid concentrations (particularly glutamine and related nitrogen/energy metabolism amino acids) in living subjects with significantly improved temporal resolution compared to existing laboratory methods. The project addresses a critical gap in physiological understanding by developing an advanced measurement capability that can support multi-hour, real-time monitoring of metabolic homeostasis at the systems level. Rather than relying on traditional sampling methods (blood draws, microdialysis) followed by benchtop analysis, the EAB sensor platform enables continuous, in vivo measurements across multiple biological environments. The anticipated outcome is a validated technology platform and supporting research data that advances understanding of acute metabolic regulation mechanisms, with potential applications to disease prevention, diagnosis, and treatment across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $594.7k | 4/7/26 |